RDB Rasayans Q1 FY27 Results: PAT Grows 35% to Rs 11 Crore on Revenue of Rs 31 Crore

RDB Rasayans Q1 FY27 results showed the specialty chemicals company delivering strong profitability growth, with standalone PAT rising 35.39% to Rs 11 crore from Rs 8 crore in Q1 FY26. Revenue grew 14.07% to Rs 31 crore from Rs 27 crore, and gross profit jumped 46.59% to Rs 8 crore, reflecting a healthy and improving margin profile for the company's specialty polymer and resin products.

The RDB Rasayans Q1 FY27 results are notable for the disproportionate PAT growth relative to revenue growth. A gross profit of Rs 8 crore on standalone revenue of Rs 31 crore implies a gross margin of approximately 25.8%, which is exceptionally high for a chemicals company and indicates significant value-added product positioning. The fact that PAT of Rs 11 crore exceeds gross profit of Rs 8 crore also suggests meaningful non-operating income contributing to the net profit.

Click Here – Get Free Investment Predictions

RDB Rasayans Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Crore)	Q1 FY26 (Rs Crore)	YoY Change
Revenue	31.00	27.00	+14.07%
Gross Profit	8.00	5.00	+46.59%
Net Profit / PAT	11.00	8.00	+35.39%

RDB Rasayans Q1 FY27 Performance Analysis

Use the Univest Screener to track RDB Rasayans live financials and Q1 FY27 results

RDB Rasayans Q1 FY27 results are impressive at the margin level. Revenue growing 14% is commendable, but gross profit growing 47% and PAT growing 35% points to a business with strong operating leverage and pricing power in its specialty chemical niche. Very few chemical companies achieve 25%+ gross margins, suggesting RDB Rasayans' product portfolio is in a differentiated, high-value segment.

The gross profit of Rs 8 crore on Rs 31 crore revenue in RDB Rasayans Q1 FY27 results is a standout feature. Combined with a PAT of Rs 11 crore that is higher than gross profit, this signals substantial other income or investment gains contributing to the net profit. Investors should analyse the standalone P&L carefully to understand whether the Rs 11 crore PAT is driven by operations or by non-operating items.

RDB Rasayans Q1 FY27 results position the company as a high-quality small-cap specialty chemicals business. The revenue base of Rs 31 crore is modest, but the earnings profile at Rs 11 crore PAT implies a PAT margin of approximately 35%, which is exceptional and indicates either a very capital-light, high-value business model or significant non-operating income.

Investors tracking RDB Rasayans Q1 FY27 results should note that with PAT exceeding gross profit by Rs 3 crore, there are likely substantial interest income or other income components boosting the reported net profit, which need to be factored into a sustainable earnings assessment.

Key Business Factors in Q1 FY27

High-Margin Specialty Chemical Portfolio

RDB Rasayans operates in specialty polymer and resin segments where value addition and proprietary formulations command premium pricing. This pricing power is the foundation of the 25%+ gross margins visible in RDB Rasayans Q1 FY27 results.

Revenue Growth and Market Penetration

The 14% revenue growth in RDB Rasayans Q1 FY27 results reflects the company's growing customer base and geographic reach in specialty chemicals. Polymer and resin products serve diverse end markets including coatings, adhesives, and construction, providing revenue stability.

Non-Operating Income Contribution

PAT of Rs 11 crore exceeding gross profit of Rs 8 crore in RDB Rasayans Q1 FY27 results suggests meaningful non-operating income from investments, interest, or other sources. This income diversifies the earnings base but also means operational PAT may be lower than the headline figure.

Dividend Details

RDB Rasayans has not declared any dividend for Q1 FY27. Given the strong profitability and high margins demonstrated in Q1 FY27 results, the company may consider a dividend announcement at the annual board meeting pending full-year performance.

FY27 Outlook

The FY27 outlook for RDB Rasayans is positive, with the specialty chemicals sector in India experiencing structural demand growth from the construction, coatings, and packaging industries. The company's high-margin product portfolio provides a durable earnings base that is less vulnerable to commodity price cycles than typical chemicals businesses.

Key risks to watch following RDB Rasayans Q1 FY27 results include the sustainability of the high PAT margins, which may include non-recurring income elements, and any changes in raw material procurement costs for polymer-grade inputs. Revenue scale-up from the Rs 31 crore Q1 base remains a medium-term aspiration.

RDB Rasayans Stock Performance

Download the Univest iOS App or Univest Android App to track RDB Rasayans share price live and stay updated on quarterly results.

RDB Rasayans shares were trading at Rs 164.10 on August 13, 2026, up 0.55% on the day, reflecting stable investor sentiment. The stock's pricing reflects confidence in the company's high-margin specialty chemicals business model validated by RDB Rasayans Q1 FY27 results.

Key Risks

PAT Composition and Non-Operating Income

In RDB Rasayans Q1 FY27 results, PAT of Rs 11 crore exceeds gross profit of Rs 8 crore, pointing to significant non-operating income. If this income is from financial investments rather than core operations, the earnings quality and sustainability are lower than the headline number suggests.

Small Revenue Scale

RDB Rasayans' standalone revenue of Rs 31 crore in Q1 FY27 results, while growing, remains modest. At this scale, even small changes in order flow or customer behaviour can cause disproportionate revenue volatility.

Input Cost Sensitivity

Specialty chemical manufacturers depend on pure-grade raw material inputs from petrochemical chains. Any spike in phenol, formaldehyde, or other polymer-grade materials could compress gross margins from the strong levels seen in RDB Rasayans Q1 FY27 results.

Conclusion

RDB Rasayans Q1 FY27 results were strong, with PAT growing 35% to Rs 11 crore and gross profit growing 47% to Rs 8 crore on 14% revenue growth. The high-margin earnings profile positions the company as one of the more profitable specialty chemicals businesses in the small-cap space.

Investors should examine the composition of PAT carefully in RDB Rasayans Q1 FY27 results to understand the operational versus non-operational earnings split. This distinction is important for projecting sustainable earnings growth in subsequent quarters and building a long-term investment case.

Frequently Asked Questions on RDB Rasayans Q1 FY27 Results

When were RDB Rasayans Q1 FY27 results announced?

Ans. RDB Rasayans Q1 FY27 results were announced on August 13, 2026, covering the April to June 2026 quarter on a standalone basis.

What was RDB Rasayans' revenue in Q1 FY27?

Ans. RDB Rasayans reported standalone revenue of Rs 31 crore in Q1 FY27, up 14.07% from Rs 27 crore in Q1 FY26.

What was RDB Rasayans' PAT in Q1 FY27?

Ans. RDB Rasayans' net profit (PAT) was Rs 11 crore in Q1 FY27, up 35.39% from Rs 8 crore in Q1 FY26.

Why is RDB Rasayans' PAT higher than its gross profit in Q1 FY27?

Ans. In RDB Rasayans Q1 FY27 results, PAT of Rs 11 crore exceeds gross profit of Rs 8 crore, which indicates significant non-operating income such as interest on investments or other income streams beyond core operations.

Did RDB Rasayans declare a dividend for Q1 FY27?

Ans. RDB Rasayans did not declare a dividend for Q1 FY27. Given the strong profitability, a dividend at the annual board meeting remains a possibility.

What is the outlook for RDB Rasayans after Q1 FY27 results?

Ans. The outlook is positive, with specialty chemicals demand from construction, coatings, and packaging remaining robust. Revenue scaling and sustaining the high-margin business model will be key for continued earnings growth through FY27.

Is RDB Rasayans a good stock after Q1 FY27 results?

Ans. RDB Rasayans Q1 FY27 results show strong profitability at a small revenue scale. Investors should evaluate earnings composition, business model, and growth runway before investing. Consult a SEBI-registered advisor for personalised guidance.